CSANZ Logo
CSANZ Logo
Welcome to the official website of the


CSANZ Logo
CSANZ Logo
Cardiac Society of Australia and New Zealand
CSANZ Logo


CSANZ Logo


CSANZ Logo

contact
links
want to join?
register
search the CSANZ website
search the CSANZ website
     







search the CSANZ website













CSANZ Directory

CSANZ Member Directory

CSANZ Guidelines

Practice Guidelines

Training and Competence

Meetings

What's On and Where

ASM Abstracts Online

News and Views

Newsletter - On the Pulse

Newsletter - CNWG

In the News

Affiliate News
Career Opportunities

Affiliate Member Area

Affiliate Calendar

Affiliate Discussion

Scholarships/ Fellowships

Working Groups


ASM Abstracts

INTERCELLULAR ADHESION MOLECULE-1 (ICAM-1) EXPRESSION BY ENDOTHELIAL CELLS AND SOLUBLE ICAM-1 LEVELS DO NOT CORRELATE DURING CARDIOPULMONARY BYPASS.

M. Vallely*1,2, PG. Bannon2, CF. Hughes2, RT. Dean1, L. Kritharides1,3.

The Heart Research Institute, Sydney1, Cardiothoracic Surgical Unit, Royal Price Alfred Hospital, Sydney2, and Department of Cardiology, Concord Hospital, Sydney3, Australia.

During inflammation, there is increased adhesion to, and penetration of, endothelium by leucocytes, and this process is dependent upon EC expression of adhesion molecules such as ICAM-1.  Cardipulmonary bypass (CPB) causes a systemic inflammatory response syndrome which is associated with increased levels of soluble ICAM-1 (sICAM-1).  It has hitherto been assumed that elevation of sICAM-1, implies upregulated tissue expression of ICAM‑-1 (tICAM-1) by EC, and that this mediates the CPB inflammatory response.  The relationship between endothelial cell (EC) expression of tICAM-1 and plasma sICAM-1 in CPB is unknown.

Plasma was taken from 10 adult patients undergoing first time, elective coronary artery bypass grafting.  Samples were taken for each patient before CPB, during CPB (before and after release of aortic cross clamp), and 3 and 24 hours after operation (post-op).  sICAM-1 levels were measured by ELISA.  The same plasma samples were incubated with passage 2 human umbilical vein EC (HUVEC) monolayers and cell surface expression of tICAM‑-1 measured by ELISA.  All plasma samples were corrected for haemodilution.  Each plasma sample was analysed in triplicate and all cell culture data were mean±SD of triplicate cultures.

sICAM-1 was increased in plasma 24 hours post-op (117% of pre‑-CPB; p=0.019), but all other samples contained identical sICAM‑-1 to the pre‑-CPB control.  Remarkably, HUVEC expression of tICAM-1 was decreased by plasma sampled 3 hours post-op (85% of control; p=0.008) and was not upregulated by any plasma sample.

We conclude that plasma sICAM-1 levels are elevated late post-op, the HUVEC expression of tICAM-1 is decreased by exposure to early post-op blood, and the EC expression of tICAM-1 and plasma sICAM-1 need not correlate during CPB.  The pro-inflammatory syndrome of CPB may not be mediated by upregulation of EC expression of tICAM-1.

[ Back to 48th ASM Abstract Index ]


Med-E-Serv